Disease/Infection News

RSS

Scientists identify common symptom patterns in post-COVID-19 vaccination syndrome

A registry study across 14 Japanese clinics analyzed 179 cases of post-COVID-19 vaccination syndrome (PCVS) and identified 493 adverse events affecting multiple organ systems. Most symptoms appeared within 90 days, but some occurred much later, highlighting the need for continued vaccine safety monitoring and better clinical frameworks for persistent post-vaccination symptoms.

16 Mar 2026

Precision mapping identifies household hotspots of schistosomiasis

High-precision mapping tools can pinpoint where schistosomiasis persists down to the household level, potentially transforming efforts to eliminate the disease affecting 250 million people, a 13-year study has found.

16 Mar 2026

Circular RNA produced by HIV boosts viral replication

For decades scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen.

13 Mar 2026

Targeting two influenza proteins may reduce viral transmission

A long-running debate in vaccine design revolves around whether a vaccine should be optimized to prevent the virus from replicating inside an infected host or prevent the virus from transmitting to others.

13 Mar 2026

Doctors warn of a deadly complication from measles outbreaks

The first sign came when Deepanwita Dasgupta was 5 and started stumbling more while playing at her home in Bangalore in southern India.

13 Mar 2026

High-dose vitamin D3 does not reduce COVID-19 severity, but may impact long COVID outcomes

In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes.

12 Mar 2026

Japan's famous matcha could reduce sneezing in people with nasal allergies

There's now another reason to love Japan's famous matcha: a study in mice suggests that the green tea powder could reduce the need to sneeze in people with nasal allergies.

11 Mar 2026

Prior flu exposure may weaken the immune response to other strains

Prior exposure to one strain of influenza virus may weaken children's ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study led by Weill Cornell Medicine investigators.

11 Mar 2026

Marburg virus enters human cells far more efficiently than Ebola

In a new study published in Nature, University of Minnesota researchers found that the Marburg virus, one of the world's deadliest pathogens with an average 73% fatality rate, is unusually efficient at getting inside human cells.

11 Mar 2026

USAID funding cuts increase financial burden for families with tuberculosis

More than a year after the second Trump administration began dismantling the US Agency for International Development (USAID), the global health consequences of this unprecedented loss in international aid continues to surface.

11 Mar 2026

Severe COVID and flu infections increase risk of lung cancer

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne B. Carter Center for Immunology Research and UVA Comprehensive Cancer Center indicates.

11 Mar 2026

DNA origami vaccine platform shows promise against multiple infectious viruses

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December 2020 and mathematical models suggest that mRNA vaccines prevented at least 14.4 million deaths from COVID-19 in the first year alone.

11 Mar 2026

Environmental conditions influence how bacteria respond to antibiotic treatments

Antibiotic susceptibility in resistant bacteria is not static. New research shows that bacteria harboring resistance genes may respond differently to antibiotics if they are tested under conditions other than those used in standard laboratory assays.

10 Mar 2026

New index provides state-level vulnerability to influenza-like illness

Infectious disease can afflict a population in complex ways. Understanding the varying risks is an equally complex challenge.

9 Mar 2026

Researchers validate Mpox antibody test during outbreak in Rwanda

An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting.

9 Mar 2026

Most pandemic viruses show little adaptation before infecting humans

A new University of California San Diego study published in Cell challenges a long-standing assumption about how animal viruses become capable of sparking human epidemics and pandemics.

9 Mar 2026

Disrupted iron levels after SARS-CoV-2 infection may trigger long COVID

Problems with iron levels in the blood and the body's ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger for long COVID, new research has discovered.

6 Mar 2026

Scientists discover how herpes simplex virus softens cells to multiply faster

Herpes simplex virus partially liquifies the tightly packed, gel-like interior of human cell nuclei to copy itself faster, a new study shows.

6 Mar 2026

Building global standards for antimicrobial policy

Antimicrobial resistance (AMR) threatens human, animal, and environmental health globally. An international team from leading institutions, including the University of Edinburgh, London School of Hygiene and Tropical Medicine, North Carolina State University, and the International Centre for Antimicrobial Resistance Solutions, identifies fundamental gaps in current mathematical modelling approaches that prevent translation of science into policy, including data limitations, knowledge gaps about AMU-AMR relationships, and the absence of international coordination mechanisms similar to climate change efforts. They call for transdisciplinary collaboration to build integrated modelling architectures.

6 Mar 2026

Melbourne’s lab-grown "skin" revolutionizes tick research

The world's first lab-based tick feeding system for bush ticks, developed by researchers at the University of Melbourne, has transformed the study of ticks and how they transmit disease. The novel, host-free technology reduces the need for animal experiments in tick studies, facilitating more ethical, reproducible research.

5 Mar 2026